Component information
No US or EU label exists for this exact combination, so information is shown for each component.
- citric acid no separate page
Use: to raise plasma pH in adult and pediatric patients with clinically significant metabolic acidosis. US FDA label
Kidney dosing: Sodium bicarbonate (single-agent)Show full dosing details
- CrCl ≥60 mL/min
- IV for metabolic acidosis (adults and children 2 years and older): 2 to 5 mEq/kg over 4 to 8 hours, by bicarbonate, total CO2, pH and clinical state (label). Treat the cause.
- CrCl 30–59 mL/min
- No kidney dose change in the label. Kidney disease and anuria increase sensitivity to the sodium load: watch for fluid overload, edema and blood pressure, and adjust other sodium sources (label 5.1). Monitor bicarbonate, sodium and potassium; avoid overshoot alkalosis. Oral tablets for CKD metabolic acidosis: consider treatment to keep serum bicarbonate from falling below 18 mmol/L, and do not overshoot the upper limit of normal; watch blood pressure, potassium and fluid status (KDIGO 2024 PP 3.10.1, 3.10.2). Each 650 mg tablet supplies about 7.7 mEq of sodium and bicarbonate (325 mg about 3.9 mEq); 8.4% solution is 1 mEq/mL (84 mg per mEq; label 3: 12.6 mg/mL = 0.150 mEq/mL). Oral doses are not in the label.
- CrCl 15–29 mL/min
- No kidney dose change in the label. Kidney disease and anuria increase sensitivity to the sodium load: watch for fluid overload, edema and blood pressure, and adjust other sodium sources (label 5.1). Monitor bicarbonate, sodium and potassium; avoid overshoot alkalosis. Oral tablets for CKD metabolic acidosis: consider treatment to keep serum bicarbonate from falling below 18 mmol/L, and do not overshoot the upper limit of normal; watch blood pressure, potassium and fluid status (KDIGO 2024 PP 3.10.1, 3.10.2). Each 650 mg tablet supplies about 7.7 mEq of sodium and bicarbonate (325 mg about 3.9 mEq); 8.4% solution is 1 mEq/mL (84 mg per mEq; label 3: 12.6 mg/mL = 0.150 mEq/mL). Oral doses are not in the label.
- CrCl <15 mL/min (not on dialysis)
- No kidney dose change in the label. Kidney disease and anuria increase sensitivity to the sodium load: watch for fluid overload, edema and blood pressure, and adjust other sodium sources (label 5.1). Monitor bicarbonate, sodium and potassium; avoid overshoot alkalosis. Oral tablets for CKD metabolic acidosis: consider treatment to keep serum bicarbonate from falling below 18 mmol/L, and do not overshoot the upper limit of normal; watch blood pressure, potassium and fluid status (KDIGO 2024 PP 3.10.1, 3.10.2). Each 650 mg tablet supplies about 7.7 mEq of sodium and bicarbonate (325 mg about 3.9 mEq); 8.4% solution is 1 mEq/mL (84 mg per mEq; label 3: 12.6 mg/mL = 0.150 mEq/mL). Oral doses are not in the label.
- Hemodialysis (intermittent)
- No dose change; anuria raises the risk of fluid overload from the sodium load (label 5.1). Dialysate bicarbonate also corrects acidosis; coordinate with the dialysis prescription (clinical judgment).
- Peritoneal dialysis
- No dose change; watch sodium load and fluid status (label 5.1).
- CRRT
- No data in label. CRRT fluids are usually bicarbonate-buffered; added IV bicarbonate is a specialist decision guided by blood gases.
- Dialyzable? Bicarbonate crosses dialysis membranes in both directions according to the dialysate bicarbonate concentration (physiology; not stated in label).
- Monitoring Blood gases or serum bicarbonate, sodium, potassium (hypokalemia as acidosis corrects), fluid status, blood pressure, edema. Extravasation site (hypertonic solutions).
From the Sodium bicarbonate monograph (renalcarematters.com, reviewed).
- sodium citrate no separate page
- tartaric acid no separate page
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Per sachet effervescent granule: 1.76 g/630 mg/720 mg/890 mg, 1760 mg/630 mg/720 mg/890 mg
- Effervescent granule: 1.76 g/890 mg/720 mg/630 mg per 4 g
Registered products in the Philippines
3 products registered with the Food and Drug Administration (FDA) Philippines list Citric acid + Sodium bicarbonate + Sodium citrate + Tartaric acid as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products3
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Citrix SodaSodium Bicarbonate + Sodium Citrate + Citric Acid + Tartaric Acid | 1.76 g/630 mg/720 mg/890 mg per sachet Effervescent GranulesPolyester/Aluminum foil/ LDPE film Sachet (Box of 1's) | Rx | Bliss GVS Pharma Ltd.India | Bliss GVS Pharma Ltd. | DR-XY47640 | Dec 29, 2026 | |
UralSodium Bicarbonate + Sodium Citrate + Citric Acid + Tartaric Acid | 1760 mg/ 630 mg/ 720 mg/ 890 mg per sachet Effervescent GranulesSachet x 4g (Box of 28's) | OTC | Aspen Pharma Pty. Ltd.Australia | Importer: Abbott Laboratories | DR-XY36847 | Oct 21, 2029 | |
UrifySodium Bicarbonate + Tartaric Acid + Citric Acid + Sodium Citrate | 1.76 g/ 890 mg/ 720 mg/ 630 mg per 4 g Effervescent GranulesAluminum Sachet x 4 g (Box of 12's) | Rx | Akums Drugs & Pharmaceuticals Ltd. (Plant I SolidIndia | Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-16571 | Apr 29, 2030 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .